(Q37181876)

18 August 2017

1 reference

title

Sex-specific differences in CYP450 isoforms in humans (English)

1 reference

18 August 2017

Marissa J Scandlyn

1

1 reference

18 August 2017

Emma C Stuart

series ordinal

2

1 reference

18 August 2017

Rhonda J Rosengren

series ordinal

3

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

Expert Opinion on Drug Metabolism & Toxicology

18 August 2017

published in

1 reference

18 August 2017

volume

4

1 reference

18 August 2017

issue

4

1 reference

18 August 2017

page(s)

413-424

1 reference

Diazepam Kinetics in Relation to Age and Sex

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Age- and gender-related differences in carbohydrate concentrations of alpha1-acid glycoprotein variants and the effects of glycoforms on their drug-binding capacities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Gender-based differences in pharmacokinetics in laboratory animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Cytochromes P450 and metabolism of xenobiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Drug-metabolizing enzymes: mechanisms and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Cytochrome P-450 3A4: regulation and role in drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

The influence of age and sex on the clearance of cytochrome P450 3A substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Effect of age and gender on the activity of human hepatic CYP3A

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Gender difference in ifosfamide metabolism by human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Sex differences in pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Influence of menstrual cycle and gender on alprazolam pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Bromazepam pharmacokinetics: influence of age, gender, oral contraceptives, cimetidine, and propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Intersubject and dose-related variability after intravenous administration of erythromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Comparison of urinary 6-beta-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Lidocaine disposition--sex differences and effects of cimetidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Sex differences in CYP3A activity using intravenous and oral midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Effects of age, gender and oral contraceptives on intramuscular midazolam pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

The erythromycin breath test predicts the clearance of midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

The distribution and gender difference of CYP3A activity in Chinese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Distinguishing a benzodiazepine agonist (triazolam) from a nonagonist anxiolytic (buspirone) by electroencephalography: kinetic-dynamic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Sensitivity to triazolam in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Race and sex influence clearance of nifedipine: results of a population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

The effect of gender on the pharmacokinetics of verapamil and norverapamil in human.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Population analyses of sustained-release verapamil in patients: effects of sex, race, and smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Do men and women differ in proximal small intestinal CYP3A or P-glycoprotein expression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Cigarette smoking, metabolic activation and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Population pharmacokinetics of riluzole in patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Effects of Gender and Age on Plasma Levels of Clozapine and Its Metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Lack of gender differences and large intrasubject variability in cytochrome P450 activity measured by phenotyping with dextromethorphan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Influence of age and gender on risperidone plasma concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Clomipramine metabolism. Model-based analysis of variability factors from drug monitoring data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Variability in the bioavailability of phenytoin capsules in males and females

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Effect of age, height, weight and sex on serum phenytoin concentration in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Pharmacogenetics, drug-metabolizing enzymes, and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Clinical consequences of cytochrome P450 2C9 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

The pharmocogenomics of warfarin: closing in on personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Cytochrome P450 2E1: its clinical and toxicological role

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Phenotype distribution and gender-related differences of CYP2E1 activity in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Bioequivalence revisited: influence of age and sex on CYP enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Hormonal effects on drug metabolism through the CYP system: perspectives on their potential significance in the era of pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Variability of gastrointestinal transit in healthy women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

The effect of hormone replacement therapy on CYP3A activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

The effects of menopause and hormone replacement therapies on prednisolone and erythromycin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Sex, age and alfentanil pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Gaps in knowledge in treating pregnant women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Pharmacokinetic studies in pregnant women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Serum protein binding of drugs during and after pregnancy in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Accelerated metabolism of nicotine and cotinine in pregnant smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Pharmacokinetics during pregnancy: evidence-based maternal dose formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Pharmacogenetics and psychopharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

S-mephenytoin, sparteine and debrisoquine oxidation: genetic polymorphisms in a Turkish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Clinical significance of the cytochrome P450 2C19 genetic polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S-mephenytoin oxidation in Tanzanians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Genetic polymorphism of S-mephenytoin hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Pharmacogenetics of cytochrome p4502D6: genetic background and clinical implication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.4.413

21 January 2018

Identifiers

DOI

10.1517/17425255.4.4.413

1 reference

18 August 2017

1 reference